About 98 results
Open links in new tab
  1. Psychedelic and Dissociative Drugs - National Institute on Drug Abuse ...

    Aug 29, 2024 · Psychedelic and dissociative drugs can temporarily alter a person’s mood, thoughts, and perceptions. Among other health effects and safety concerns, people who use these substances …

  2. Could psychedelics harness neuroplasticity to treat addiction and other ...

    Jan 13, 2026 · If psychedelic-based therapies were to gain FDA approval, protocols to train clinicians will be needed for these therapies to enter mainstream psychiatric treatment, as well as questions …

  3. Psilocybin (Magic Mushrooms) | National Institute on Drug Abuse

    Jan 24, 2024 · Learn more about NIDA research on the therapeutic potential of psychedelic and dissociative drugs, including psilocybin. Along with other partners at the National Institutes of Health, …

  4. Psychedelic and Dissociative Drugs as Medicines

    Jan 24, 2024 · Are psychedelic or dissociative drugs already approved as medicines? Are psychedelic and dissociative drugs being studied as potential medical treatments? What is psychedelic-assisted …

  5. Methamphetamine | National Institute on Drug Abuse (NIDA)

    Nov 20, 2024 · Methamphetamine is a lab-made (synthetic) stimulant with high addiction potential. When sold as shiny bluish-white rocks or crystals, it may be called “crystal meth,” “Tina,” or “ice.” …

  6. MDMA (Ecstasy/Molly) | National Institute on Drug Abuse (NIDA)

    Apr 19, 2024 · MDMA, also called Molly or Ecstasy, is a lab-made (synthetic) drug that has effects similar to stimulants like methamphetamine, although some researchers and organizations consider …

  7. Ketamine | National Institute on Drug Abuse (NIDA)

    Apr 9, 2024 · Ketamine is a chemical compound used as an anesthetic in humans and animals. 1,2 It was developed decades ago as a less toxic alternative to the drug phencyclidine (PCP), which was …

  8. Drogas psicodélicas y disociativas - National Institute on Drug Abuse ...

    Learn more about NIDA’s research on the health effects and therapeutic potential of psychedelic and dissociative drugs.

  9. NIDA IRP Technology Resource Initiative Featured Paper

    Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states Published in Science. Authors J Muir, S Lin, I K Aarrestad, H R Daniels, J Ma 1,2, L Tian, D E Olson, C K Kim …

  10. Research Report Series Hallucinogens and dissociative drugs— which have street names like acid, angel dust, and vitamin K—distort the way a user perceives time, motion, colors, sounds, and self. …